For help on how to get the results you want, see our search tips.
11 results
Medicine
Summaries of opinion Remove Summaries of opinion filter
Opinions on maximum residue limits Remove Opinions on maximum residue limits filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Categories
Human Remove Human filter
Application type
Initial authorisation Remove Initial authorisation filter
Post-authorisation Remove Post-authorisation filter
Medicine type
Orphan medicine Remove Orphan medicine filter
-
List item
Summary of opinion: Elzonris (updated)
tagraxofusp, opinion date: 23/07/2020, Positive, Last updated: 13/11/2020 -
List item
Summary of opinion: Deltyba
delamanid, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Blincyto
blinatumomab, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Libmeldy
opinion date: 15/10/2020, Positive, Last updated: 16/10/2020 -
List item
Summary of opinion: Fintepla
opinion date: 15/10/2020, Positive, Last updated: 16/10/2020 -
List item
Summary of opinion: Obiltoxaximab SFL
opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Crysvita
burosumab, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Symkevi
tezacaftor, ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Kyprolis
carfilzomib, opinion date: 12/11/2020, Positive, Last updated: 13/11/2020